Home › Funds › Opaleye Management Inc. › DERM

Opaleye Management Inc. position in DERM

JOURNEY MED CORP · Health Care

Opaleye Management Inc. reported holding 350,000 shares of DERM (JOURNEY MED CORP) in its Q2 2026 13F filing — a position valued at US$2.5M, representing 0.22% of its reported portfolio and ranking #45 among its reported holdings. Opaleye Management Inc. has disclosed DERM holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)350.00K sh
Reported value held$2.48M
Portfolio Weight0.22%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s DERM position evolved

Opaleye Management Inc. first disclosed a stake in DERM in Q1 2025 at 69,323 shares (US$409K). The position peaked in Q4 2025 at 975,000 shares, worth US$7.5M. Across 6 filings, Opaleye Management Inc. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 350,000 shares valued at US$2.5M — a reduction of -610,000 shares quarter over quarter.. Notable position changes include a 37% increase in Q2 2025 (shares were roughly flat over the following quarter), a 922% increase in Q3 2025 (shares rose 8% over the following quarter), a 64% trim in Q2 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 69.32K $409.01K New
Q2 2025 95.00K $682.10K Add
Q3 2025 971.06K $6.91M Add
Q4 2025 975.00K $7.52M Hold
Q1 2026 960.00K $4.50M Reduce
Q2 2026 350.00K $2.48M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DERM and 13F data

DERM (JOURNEY MED CORP) is a Health Care company. 43 other funds we track also report a position in DERM — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$11.4M), Pale Fire Capital SE (US$3.7M), AMERICAN FINANCIAL GROUP INC (US$1.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DERM

All DERM fund holders →

FAQ

How long has Opaleye Management Inc. held DERM?

Opaleye Management Inc. has disclosed DERM holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Opaleye Management Inc.'s current position in DERM?

As of Q2 2026, Opaleye Management Inc. holds 350.00K shares of DERM (JOURNEY MED CORP), valued at $2.48M, representing 0.22% of its reported portfolio and ranking #45.

Has Opaleye Management Inc. been buying or selling DERM?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. reduced its position in DERM. The position peaked in Q4 2025 at 975.00K shares.

Which other funds hold DERM?

Other major institutional holders of DERM include TANG CAPITAL MANAGEMENT LLC, Pale Fire Capital SE, AMERICAN FINANCIAL GROUP INC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.